Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GCLC | P48506 | 1/20 | 0.34 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5013300 | 0.97 | CHRM1 (0.39) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5014260 | 0.97 | CHRM1 (0.39) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5022363 | 0.97 | CHRM1 (0.39) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5014288 | 0.97 | CHRM1 (0.39) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Octane SCHEMBL27498783 | 0.89 | GPR84 (0.45) | TDP1RECQLCA2MAPK1 | |
| Methacrylic Acid SCHEMBL28000399 | 0.85 | TGFBR1 (0.39) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Pyridine SCHEMBL28462448 | 0.84 | NAPRT (0.33) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Toluene SCHEMBL3695874 | 0.82 | SRC (0.43) | TDP1RECQLMMP2MMP9SRC | |
| SCHEMBL6631114 | 0.82 | RECQL (0.35) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL565205 | 0.80 | MMP2 (0.34) | CHRM1AKR1A1CHRM3HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947123-B2 | Synthetic caustic composition | FLUID ENERGY GROUP LTD. (CA) | 2021-03-16 | — | — | US | claimed |
| US-20190144741-A1 | NOVEL SYNTHETIC CAUSTIC COMPOSITION | HSBC BANK MIDDLE EAST LIMITED (AE) | 2019-05-16 | — | — | US | claimed |
| EP-0613482-B1 | METHOD OF PREPARING ALKYL AND/OR ALKENYL OLIGOGLYCOSIDES | HENKEL KGAA (DE) | 1997-06-04 | — | — | EP | claimed |
| EP-0373038-B1 | New lysosphingolipid derivatives | FIDIA SPA (IT) | 1997-03-05 | — | — | EP | claimed |
| US-5480979-A | REACTING GLYCOSE WITH FATTY ALCOHOL IN PRESENCE OF ACID CATALYST, I.E., SULFOMONOCARBOXYLIC ACID, ANHYDRIDE OF SULFOMONOCARBOXYLIC ACID AND/OR MIXED CYCLIC SULFONIC ACID CARBOXYLIC ACID ANHYDRIDE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1996-01-02 | — | — | US | claimed |
| EP-0410883-A2 | Di-lysogangliosides derivatives | FIDIA S.p.A. (IT) | 1991-01-30 | — | — | EP | claimed |
| EP-0373038-A2 | New lysosphingolipid derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | claimed |
| JP-60228488-A | — | — | None | — | — | JP | disclosed |
| US-20260018761-A1 | BATTERY | MURATA MANUFACTURING CO (JP) | 2026-01-15 | — | — | US | disclosed |
| US-20250210797-A1 | SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2025-06-26 | — | — | US | disclosed |
| US-20250183467-A1 | BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2025-06-05 | — | — | US | disclosed |
| US-20250112301-A1 | BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2025-04-03 | — | — | US | disclosed |
| EP-3537515-B1 | ELECTRODE AND ELECTROCHEMICAL DEVICE | DAIKIN IND LTD (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-0373038-A2 | New lysosphingolipid derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | disclosed |
| EP-0373039-A2 | New lysoganglioside derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | disclosed |
| US-4642359-A | DIACYLATING ISOOLEFINS WITH CARBOXYLIC ACID ANHYDRIDES | EASTMAN KODAK COMPANY (US) | 1987-02-10 | — | — | US | disclosed |
| JP-S60228488-A | BICYCLOORTHOESTER COMPOUND | TOKUYAMA SODA CO LTD | 1985-11-13 | — | — | JP | disclosed |
| EP-0096641-A2 | Process for preparing pyrylium salts | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-12-21 | — | — | EP | disclosed |
| US-3985722-A | Process for preparing N-higher aliphatic acyl derivatives of amino acids, peptides or proteins | AJINOMOTO CO., INC. (JA) | 1976-10-12 | — | — | US | disclosed |
| US-3959465-A | Process for preparing concentrated titanium mineral | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260018761-A1 | BATTERY | GJB2, MYOC, KCNJ11 | CHRM1 2204/4885AKR1A1 4582/4885CHRM3 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.